Ilaris (canakinumab)

What it is

Ilaris (canakinumab) is a biologic medicine that blocks interleukin-1 beta (IL-1β) — a protein strongly involved in inflammation. It was the first biologic approved for gout flares, for adults who cannot take, or have not responded well to, the usual flare medicines such as anti-inflammatory pills and colchicine. A single injection can both calm an active flare and lower the chance of another one in the following months. It also treats Still’s disease (a rare inflammatory condition affecting children and adults) and a group of rare inherited fever syndromes.

Before starting

Before a gout-flare dose, we confirm the joint problem is really gout and not infection — a hot, swollen joint can occasionally be a joint infection, which needs entirely different treatment, and an infection must be ruled out or treated before an immune-calming injection is given. We also screen for tuberculosis (TB) before longer-term use, because IL-1 blockade can allow a hidden TB infection to become active. Live vaccines should be avoided around treatment, and Ilaris is not combined with other IL-1 blockers or TNF blockers, as stacking immune suppression raises infection risk without added benefit.

How it’s given

For a gout flare, it is a single injection under the skin, given in our office. If another flare occurs and another dose is needed, doses are spaced at least 12 weeks apart. For Still’s disease, it is given every 4 weeks, with the dose based on body weight. There is nothing to take at home, and most patients return to normal activities the same day — apart from the sore joint itself, which settles as the flare calms.

What to expect

For a gout flare, pain and swelling usually begin easing within the first few days, and studies show a lower chance of another flare over the following months compared with steroid treatment. The most common side effects are cold symptoms (runny nose, sore throat), dizziness, flushing, nausea, and soreness where the injection was given. Because IL-1 blockade lowers part of infection defence, call us promptly for fever or an infection that is not improving. Note that Ilaris treats flares — it does not lower uric acid, so if you also take a uric-acid-lowering pill, keep taking it as prescribed.

Everyday guidance

Keep a note of flare dates and which joint was involved; the pattern helps us judge whether flare prevention is working and whether your long-term gout plan needs adjusting. If a new hot, swollen joint appears with fever, call the same day — that combination always needs checking for infection. Keep taking any daily uric-acid medicine you have been prescribed, even between flares; that is the treatment that prevents future attacks. Tell other clinicians you have received an IL-1 blocker. Questions: call (361) 400-7700.